ascopost.com Overview
Alexa Rank
215,512
Daily Pageviews per Visitor
1.3
Daily Time on Site
1:47
Bounce Rate
83.2%
Search Traffic
39.2%
Total Sites Linking In
850
Traffic Statistics
Audience Geography
| Visitors by Country | Site Traffic |
|---|---|
|
China |
62.9% |
|
United States |
9.4% |
|
Spain |
8.7% |
| Rankings by Country | Alexa Rank # |
|---|---|
|
China |
32,832 |
|
United States |
144,774 |
|
Spain |
19,511 |
Keyword Analysis
Top Keywords
| Top Keywords | Search Traffic |
|---|---|
|
mohs surgery |
1.76% |
|
neratinib |
1.19% |
|
residual cancer burden calculator |
1.03% |
|
double hit lymphoma |
0.86% |
|
asco post |
0.67% |
Audience Report
Audience Overlap
Similar sites that share the same visitors and search keywords with this site.
| Similar Sites | Alexa Rank |
|---|---|
| 36,334 | |
| 223,543 | |
| 83,183 | |
| 440,577 | |
| 225,240 |
Social Engagement
| Websites | Total Articles | Engagement |
|---|---|---|
| 11,242 | 8 | |
| 7,759 | 22 | |
| 6,912 | 7 | |
| 5,195 | 7 | |
| 1,205 | 37 |
| Topic | Total Articles | Engagement |
|---|---|---|
|
oncology |
3,032 | 8 |
|
patients |
2,435 | 7 |
|
chemotherapy |
1,487 | 7 |
Keyword Opportunities
Keyword Gaps
| Keyword | Competitors Traffic |
Search Popularity |
|---|---|---|
|
entrectinib |
36 | 23 |
|
bendamustine rituximab |
35 | 12 |
|
nktr-214 |
33 | 23 |
|
gog 258 |
33 | 12 |
These keywords are driving traffic to competitors, but not to this site.
Easy-to-Rank Keywords
| Keyword | Relevance to this site |
Search Popularity |
|---|---|---|
|
multiple myeloma |
56 | 53 |
|
momelotinib |
54 | 15 |
|
oncology |
66 | 50 |
|
nktr-214 |
59 | 23 |
These are popular keywords within this site's competitive power.
Buyer Keywords
| Keyword | Competitors Traffic |
Organic Competition |
|---|---|---|
|
metastatic breast cancer good news |
38 | 60 |
|
(university of cincinnati) asco review |
31 | 11 |
|
folfox vs capox |
31 | 19 |
|
pembrolizumab vs nivolumab |
30 | 58 |
These keywords show a high purchase intent.
Optimization Opportunities
| Keyword | Search Popularity |
Organic Share of Voice |
|---|---|---|
|
checkmate 459 results |
12 | 4.35% |
|
niraparib |
29 | 1.58% |
|
apalutamide |
31 | 1.3% |
|
daratumumab |
34 | 0.71% |
These are very popular keywords that are already driving some traffic to this site.
Competitive Analysis
| Websites | Search Traffic |
|---|---|
| 66% | |
| 55.2% | |
| 51.6% | |
| 39.2% | |
| 38.4% |
| Website | Referral Sites |
|---|---|
| 4.1 k | |
| 3.5 k | |
| 850 | |
| 611 | |
| 328 |
Copyright © 2024 AlreadyCoded